Nxera Pharma Co Ltd (FRA:JSS)
€ 8.75 -0.3 (-3.31%) Market Cap: 828.49 Mil Enterprise Value: 982.41 Mil PE Ratio: 0 PB Ratio: 2.12 GF Score: 65/100

Sosei Group Corporation - Special Call Transcript

Sep 12, 2019 / 12:30AM GMT
Release Date Price: €18.55 (-3.89%)
Shinichi Tamura
Sosei Group Corporation - Founder, Executive Chairman, Representative Executive Officer, President & CEO

[Interpreted] Good morning, ladies and gentlemen. Thank you very much for your attendance to R&D Day despite your very busy schedule. Oftentimes, the management and IR team present to you about GPCR drug discovery, but the details of science is in depth, and since we do not have any R&D facilities inside Japan, there is a difficulty of having familiarizing yourself to this technology. So the aim of today's event is to have the presentations by the representative of the researchers who are involved in GPCR drug discovery and to deepen your understanding about the background science and to understand the characteristics of GPCR and the overview of business plan based on that scientific knowledge.

First of all, the very eminent speaker in the area of structural physiology, which is very closely related with our company's drug discovery process, is Dr. Fujiyoshi from Tokyo Medical Dental and University (sic) [Tokyo Medical and Dental University]. He will be making a

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot